Live tape
Top 8, mentions 7d13,280TSLA3,012 mentions▲ +0.06SPCX2,578 mentions▲ +0.08GOOGL1,769 mentions▲ +0.03META1,411 mentions▲ +0.05CRWV1,262 mentions▲ +0.04NVDA1,174 mentions▲ +0.07QQQ1,131 mentions▲ +0.05NFLX943 mentions▲ +0.03

Equity · Healthcare

UTHR

NASDAQ

United Therapeutics (UTHR)

$554 +2.03% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 20, 2026

Reddit mentioned UTHR 3 times in the 30 days to 21 October 2026, across 2 of the communities we track. All of them were scored for sentiment: 33% read bullish, 0% bearish and 67% neither. Reddit data updated 21 October 2026.

Price · Chart
18 sessions
$575 $475 25 Sep 20 Oct

The line runs $475.61 on 25 September through $554 on 20 October, on a scale from $475 to $575. Days the market did not trade hold the previous close, flat.

Market cap $23.8B
P/E (TTM) 19.9
52-week range $414.67 – $596
Avg volume 76.3K
Mentions · 30d 3

as of Oct 20, 2026

United Therapeutics (UTHR) · crowd attention × price

Share ↗
3 mentions

Day13 Oct 2026

MENTIONS10–3 / day
PRICE$544$475–$575
UTHR over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed, diagonally hatched over days we hold no close for.per day0123usd$475$500$525$550$57522 Sep29 Sep7 Oct14 Oct21 Oct
UTHR over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed, diagonally hatched over days we hold no close for.22 Sep7 Oct21 Oct
The Distributed Sentinel 21 Oct 2026

UTHR's busiest day for Reddit mentions was also its highest close of the window — 2 mentions and $571.12 on 1 October

This chart in words

The chart plots daily Reddit mentions of UTHR over the 30 days to 21 October 2026: 3 in total, busiest on 1 October with 2, and 1 on the last day counted. Across this window the close ran between $475.61 on 25 September and $571.12 on 1 October. The line is the daily close over the same window: $475.61 on 25 September, $554 on 20 October. Of those days, 18 were trading sessions and the other 12 are hatched on the chart. On 8 of them no session took place, and the last close before it is carried forward rather than plotted; on 4 of them we hold no close at all, which is a gap in our own record rather than a closure we can prove.

United Therapeutics (UTHR) on Reddit · 30d

n = 3 scored · Method

In the 30 days to 22 Oct 2026, United Therapeutics drew 3 Reddit mentions in the finance subreddits we track, 3 of them scored for sentiment.

3 mentions of UTHR were scored for sentiment in these 30 days, so each one carries 1/3 of any share. A split that coarse states the sample size and not the crowd — so none is drawn. The chart on this page applies the same 5-mention floor to every day it plots.

Where UTHR is discussed

(30d)
r/wallstreetbets 67% 2 +0.04
r/stocks 33% 1 +0.06

United Therapeutics (UTHR) insider trades

SEC Form 4 · last 90 days · newest reported trade 19 Oct 2026

In the 90 days to 22 Oct 2026, United Therapeutics insiders reported 69 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 8 Oct 2026, show no open-market purchase.

Open-market buys 0
Open-market sells 69
Net sold $330.51M
Non-trade filings 69
Date Insider Type Shares Value
19 Oct 2026 ROTHBLATT MARTINE A Chairperson & CEO Sell 9,500 $5.16M
16 Oct 2026 ROTHBLATT MARTINE A Chairperson & CEO Sell 9,500 $5.08M
15 Oct 2026 MAHON PAUL A EVP & GENERAL COUNSEL Sell 8,300 $4.52M
15 Oct 2026 ROTHBLATT MARTINE A Chairperson & CEO Sell 9,500 $5.19M
14 Oct 2026 ROTHBLATT MARTINE A Chairperson & CEO Sell 9,500 $5.13M
13 Oct 2026 ROTHBLATT MARTINE A Chairperson & CEO Sell 9,500 $5.18M
12 Oct 2026 ROTHBLATT MARTINE A Chairperson & CEO Sell 9,500 $5.23M
09 Oct 2026 ROTHBLATT MARTINE A Chairperson & CEO Sell 9,500 $5.18M
08 Oct 2026 ROTHBLATT MARTINE A Chairperson & CEO Sell 9,500 $5.08M
07 Oct 2026 ROTHBLATT MARTINE A Chairperson & CEO Sell 9,500 $5.22M
06 Oct 2026 ROTHBLATT MARTINE A Chairperson & CEO Sell 9,500 $5.12M
05 Oct 2026 ROTHBLATT MARTINE A Chairperson & CEO Sell 9,500 $5.15M

Showing the 12 most recent of 69 open-market trades in this window. The figures above count all of them.

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
19 Oct 2026 ROTHBLATT MARTINE A Chairperson & CEO Option exercise 9,500 $1.12M
16 Oct 2026 ROTHBLATT MARTINE A Chairperson & CEO Option exercise 9,500 $1.12M
15 Oct 2026 MAHON PAUL A EVP & GENERAL COUNSEL Option exercise 8,300 $1.21M
15 Oct 2026 ROTHBLATT MARTINE A Chairperson & CEO Option exercise 9,500 $1.12M
14 Oct 2026 ROTHBLATT MARTINE A Chairperson & CEO Option exercise 9,500 $1.12M
13 Oct 2026 ROTHBLATT MARTINE A Chairperson & CEO Option exercise 9,500 $1.12M
12 Oct 2026 ROTHBLATT MARTINE A Chairperson & CEO Option exercise 9,500 $1.12M
09 Oct 2026 ROTHBLATT MARTINE A Chairperson & CEO Option exercise 9,500 $1.12M
08 Oct 2026 ROTHBLATT MARTINE A Chairperson & CEO Option exercise 9,500 $1.12M
07 Oct 2026 ROTHBLATT MARTINE A Chairperson & CEO Option exercise 9,500 $1.12M
06 Oct 2026 ROTHBLATT MARTINE A Chairperson & CEO Option exercise 9,500 $1.12M
05 Oct 2026 ROTHBLATT MARTINE A Chairperson & CEO Option exercise 9,500 $1.12M

Showing the 12 most recent of 69 compensation filings in this window. The figures above count all of them.

United Therapeutics (UTHR) reported financials

SEC EDGAR XBRL SEC EDGAR

United Therapeutics reported revenue of $3.2B for the fiscal year ended 31 Dec 2025. Net income over the same period was $1.3B.

Figure Reported Period
Revenue $3.2B 31 Dec 2025 fiscal year
Net income $1.3B 31 Dec 2025 fiscal year
Diluted EPS $27.86 31 Dec 2025 fiscal year
Total assets $7.2B 30 Jun 2026 at period end
Total equity $6.4B 30 Jun 2026 at period end

United Therapeutics (UTHR) earnings

SEC EDGAR

United Therapeutics last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of $7.27; no next date is announced in SEC filings yet.

Date Period EPS Revenue
30 Jun 2026 Q2 2026 $7.27 —
31 Mar 2026 Q1 2026 $5.82 —
31 Dec 2025 FY 2025 $27.86 —
30 Sep 2025 Q3 2025 $7.16 —
30 Jun 2025 Q2 2025 $6.41 —
31 Mar 2025 Q1 2025 $6.63 —
31 Dec 2024 FY 2024 $24.64 —
30 Sep 2024 Q3 2024 $6.39 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

United Therapeutics (UTHR) institutional holders (13F)

SEC Form 13F SEC EDGAR

12 of the 45 institutional funds we track reported a United Therapeutics position for the quarter ended 30 Jun 2026 — a combined $1.9B; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Renaissance Technologies Held (±25%) −4.4% shares 1,708,739 $925.8M
AQR Capital Management Trimmed −33.9% shares 546,002 $294.6M
Millennium Management Added +166.7% shares 409,074 $221.6M
Citadel Advisors Held (±25%) −15.5% shares 304,692 $165.1M
Point72 Asset Management Added +34.7% shares 201,159 $109.0M
Man Group Added +74.1% shares 134,890 $73.1M
Bridgewater Associates Held (±25%) +0.1% shares 111,326 $60.3M
Fisher Asset Management Held (±25%) −1.7% shares 33,836 $18.3M
Marshall Wace Trimmed −60.2% shares 30,231 $16.4M
Tudor Investment Corp New position 12,667 $6.9M

Showing the 10 largest of 12 reported positions. The figures above count all of them.

United Therapeutics (UTHR) fails-to-deliver

SEC CNS data SEC

On 18 Sep 2026, 6,915 shares of United Therapeutics failed to deliver (about $3.4M).

Settlement date Shares failed Notional % of shares out
18 Sep 2026 6,915 $3.4M 0.016%

Congressional trades in United Therapeutics (UTHR)

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in United Therapeutics is a sale by Lisa C. McClain (house, MI), dated 31 Oct 2025.

Date Member Type Amount
31 Oct 2025 filed 21 Nov 2025 Lisa C. McClain house · Republican–MI Sale $1K–$15K
30 Oct 2025 filed 21 Nov 2025 Lisa C. McClain house · Republican–MI Purchase $1K–$15K
30 Oct 2025 filed 21 Nov 2025 Lisa C. McClain house · Republican–MI Sale $1K–$15K

United Therapeutics (UTHR): frequently asked questions

From live data

Have United Therapeutics insiders bought or sold shares recently?

In the 90 days to 22 Oct 2026, United Therapeutics insiders reported 69 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 8 Oct 2026, show no open-market purchase. A further 69 filings were grants, awards, gifts or exercises rather than open-market trades.

How many institutions hold United Therapeutics?

12 of the 45 institutional funds we track reported a United Therapeutics position for the quarter ended 30 Jun 2026, per SEC Form 13F filings.

Has United Therapeutics had fails-to-deliver recently?

Yes. The most recent SEC fails-to-deliver record for United Therapeutics is dated 18 Sep 2026, when 6,915 shares failed to deliver.

When did United Therapeutics last report earnings?

United Therapeutics last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of $7.27; no next date is announced in SEC filings yet.

What exchange is United Therapeutics listed on?

United Therapeutics trades on NASDAQ under the ticker UTHR.

What is Reddit saying about United Therapeutics?

United Therapeutics was mentioned 0 times in the last 7 days across the finance subreddits we track, and 3 times over the trailing 30 days. Of 3 classified mentions, 33% read bullish, 0% bearish and 67% neutral. Crowd sentiment is a social signal, not investment advice.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. RedditReddit ingest across the tracked finance subreddits
  4. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  5. SEC EDGARSEC EDGAR 13F filings
  6. SECSEC fails-to-deliver (CNS) data
  7. House disclosuresU.S. House of Representatives financial disclosures
  8. SEC EDGARValuation computed from SEC EDGAR filings